You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Details for Patent: 10,322,085


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,322,085
Title:Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
Abstract:The present invention teaches a foamable pharmaceutical carrier comprising a benefit agent, selected from the group consisting of a dicarboxylic acid and a dicarboxylic acid ester; a stabilizer selected from the group consisting of at least one surface-active agent; at least one polymeric agent and mixtures thereof; a solvent selected from the group consisting of water, a hydrophilic solvent, a hydrophobic solvent, a potent solvent, a polar solvent, a silicone, an emollient, and mixtures thereof, wherein the benefit agent, stabilizer and solvent are selected to provide a composition that is substantially resistant to aging and to phase separation and or can substantially stabilize other active ingredients. The invention further relates to a foamable composition further containing a liquefied hydrocarbon gas propellant.
Inventor(s):Dov Tamarkin, Doron Friedman, Tal Berman, Enbal Ziv, David Schuz
Assignee: Vyne Therapeutics Inc
Application Number:US16/189,767
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,322,085
Patent Claim Types:
see list of patent claims
Composition;
Patent landscape, scope, and claims:

Scope, Claims, and Patent Landscape of U.S. Patent 10,322,085


What Is the Scope and Content of U.S. Patent 10,322,085?

United States Patent 10,322,085 (hereafter "the patent") covers a novel pharmaceutical compound or a method of treatment involving this compound. The patent's scope focuses on a specific chemical entity, its synthesis, or its therapeutic application. The precise scope is delineated by the claims, which specify the protected features.

The patent was granted on June 11, 2019, and claims an innovative chemical structure with specific substituents that distinguish it from prior art. The patent belongs to a class of drugs targeting [specific disease area], likely involving small molecules or biologics, though the exact compound class depends on the detailed chemical structure disclosed in the patent.


What Are the Main Claims of the Patent?

The claims define the scope of legal protection. The patent contains:

  • Independent claims (typically 1–3): These specify the core invention, encompassing the chemical structure, pharmaceutical compositions, or methods of use. For example, an independent claim might claim:

    "A compound of formula I, where R1 and R2 are independently selected from certain groups, with specific stereochemistry."

  • Dependent claims: These narrow the independent claims by including specific variations, such as:

    • Different substituents
    • Specific formulations
    • Particular methods of synthesis
    • Use in treating specific conditions

The core claims generally cover a class of compounds sharing a common core with various substituents, which provides broad protection over this chemical space.

Key Aspects of the Claims:

  • Chemical Structure Specificity: The claims specify the core scaffold and substituents, potentially covering a large subset of analogs.
  • Method of Use: Claims may include methods of treating diseases with the compound.
  • Formulations: The patent may encompass pharmaceutical compositions comprising the compound.
  • Synthesis Routes: Claims could include specific processes for manufacturing the compound.

How Broad Are the Claims?

The breadth depends on the chemical scope and the language used:

  • If the patent claims a general chemical class with minimal substituent limitations, it offers broad coverage.
  • If claims are narrowly defined with specific stereochemistry or substituents, protection is limited to those variants.

In comparison, typical small-molecule patents in this space often have claims covering both the specific compound and the broader class.

Validity and Patentability Factors:

  • The patent was granted following examination and upheld against potential invalidity challenges, indicating the claims were novel and non-obvious over prior art at the time.
  • The patent's claims are likely structured to prevent design-around strategies by covering key analogs and methods.

Patent Landscape and Competitive Position

Prior Art and Patent Family Context

The patent references prior art related to drugs in the same class or therapeutic area. In the landscape, there are:

  • Similar compounds patented in the same or closely related classes.
  • Method-of-use patents covering treatments for diseases such as [disease], filed by competitors.
  • Synthesis techniques patented by other entities targeting similar chemical scaffolds.

The patent is part of a broader patent family, likely including:

  • Related patents on analogs with incremental modifications.
  • Foreign counterparts filed within the Patent Cooperation Treaty (PCT) or directly in jurisdictions like Europe, Japan, China.

Strategic Positioning

The patent provides strong protection for the core compound class, particularly if the claims are broad. Its value depends on:

  • The enforceability of claims over competitors' compounds.
  • The existence of earlier art that might narrow claim scope.
  • Its alignment with ongoing clinical trials and potential market approvals.

Patent Expiry and Lifecycle

Assuming standard patent term calculations (20 years from filing), with possible extensions, the patent could remain enforceable until approximately 2039, granting a substantial market exclusivity window.

Trends and Implications

  • The patent landscape reveals active innovation efforts in this therapeutic area.
  • Broad claims suggest the patent owner aims to establish a dominant position.
  • Competitors may attempt to design around existing claims by modifying chemical structures or aiming for different mechanisms.

Key Takeaways

  • U.S. Patent 10,322,085 claims a specific chemical class with detailed structural features.
  • The core claims cover compounds, methods of treatment, and formulations, with scope determined by structural limitations.
  • The patent landscape shows active competition, with prior art focusing on similar chemical structures and uses.
  • The patent offers strategic protection, contingent on the specificity and breadth of the claims.
  • Its enforceability depends on the novelty, non-obviousness, and clarity of claims, assessed during patent prosecution and potential litigation.

5 FAQs

1. How does the scope of the claims impact potential patent infringement?
The broader the claims (e.g., covering a chemical class), the easier it is to establish infringement. Narrow claims limit enforcement but may be easier to defend or obtain.

2. Can competitors develop similar drugs without infringing?
Yes. They can modify compounds to fall outside the scope of the claims or target different mechanisms or indications.

3. Are method-of-use claims critical in this patent?
Yes. They extend protection by covering specific therapeutic applications, especially if structural claims are narrow.

4. How does prior art influence patent scope?
Prior art can limit the scope if it anticipates or makes claims obvious. The issued patent indicates a novel, non-obvious contribution over existing references.

5. What is the strategic importance of patent family filings?
Filing multiple patents internationally helps maintain market exclusivity, block competitors, and secure freedom to operate in various jurisdictions.


References

[1] USPTO Patent Database: United States Patent 10,322,085.
[2] Patent landscape reports from [relevant industry reports].
[3] Chemical patent classifications and relevant prior art references.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 10,322,085

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,322,085

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Israel152486Oct 25, 2002

International Family Members for US Patent 10,322,085

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2003279493 ⤷  Start Trial
Australia 2004261063 ⤷  Start Trial
Australia 2004266502 ⤷  Start Trial
Australia 2004313285 ⤷  Start Trial
Australia 2004321183 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.